OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Paradigms of Old Psychedelics in Schizophrenia
Danish Mahmood, Sattam Khulaif Alenezi, Md Jamir Anwar, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 640-640
Open Access | Times Cited: 25

Showing 25 citing articles:

G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders
Thian‐Sze Wong, Guangzhi Li, Shiliang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 60

Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways
Jitendra Kumar Sinha, Anchal Trisal, Shampa Ghosh, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102211-102211
Closed Access | Times Cited: 13

Therapeutic modulation of the kynurenine pathway in severe mental illness and comorbidities: A potential role for serotonergic psychedelics
Antonella Campanale, Antonio Inserra, Stefano Comai
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 134, pp. 111058-111058
Open Access | Times Cited: 5

Molecular and Medical Aspects of Psychedelics
Adam Wojtas, Krystyna Gołembiowska
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 241-241
Open Access | Times Cited: 8

EMBARK Psychedelic Therapy for Depression
Bill Brennan, Alex Belser
(2024)
Closed Access | Times Cited: 2

Expert Opinion on Psychedelic-Assisted Psychotherapy for People with Psychopathological Psychotic Experiences and Psychotic Disorders
Joseph La Torre, Mehdi Mahammadli, Sonya C. Faber, et al.
International Journal of Mental Health and Addiction (2023) Vol. 22, Iss. 2, pp. 913-937
Closed Access | Times Cited: 5

Spectroscopic behavior of bufotenine and bufotenine N-oxide: Solvent and pH effects and interaction with biomembrane models
Gustavo Almeida e Silva, Vinícius Galvão Wakui, Lucília Kato, et al.
Biochimica et Biophysica Acta (BBA) - Biomembranes (2024) Vol. 1866, Iss. 4, pp. 184304-184304
Closed Access | Times Cited: 1

Introduction to the EMBARK Approach
Bill Brennan, Alex Belser
(2024), pp. 31-69
Closed Access

Preparation Sessions
Bill Brennan, Alex Belser
(2024), pp. 132-166
Closed Access

Bringing It Home and Carrying It Forward
Bill Brennan, Alex Belser
(2024), pp. 253-262
Closed Access

Considerations Prior to Meeting With a Participant
Bill Brennan, Alex Belser
(2024), pp. 93-131
Closed Access

INTRODUCTION: A New Approach for the Whole Person
Bill Brennan, Alex Belser
(2024), pp. 1-9
Closed Access

Choosing Suggested Integration Goals
Bill Brennan, Alex Belser
(2024), pp. 269-269
Closed Access

Working Within the EMBARK Domains Cheat Sheet
Bill Brennan, Alex Belser
(2024), pp. 268-268
Closed Access

Medicine Sessions
Bill Brennan, Alex Belser
(2024), pp. 167-203
Closed Access

Therapist Aims Cheat Sheet
Bill Brennan, Alex Belser
(2024), pp. 266-267
Closed Access

An Overview of Psychedelic-Assisted Therapy
Bill Brennan, Alex Belser
(2024), pp. 10-30
Closed Access

Personal Care for the Therapist
Bill Brennan, Alex Belser
(2024), pp. 263-265
Closed Access

Integration Sessions
Bill Brennan, Alex Belser
(2024), pp. 204-252
Closed Access

Authors’ Note
Bill Brennan, Alex Belser
(2024), pp. xv-xv
Closed Access

EMBARK Mechanisms of Change in the Treatment of Depression
Bill Brennan, Alex Belser
(2024), pp. 70-92
Closed Access

Next generation antidepressants with novel mechanisms for treatment resistant depression
Mu‐Hong Chen, Pei‐Chi Tu, Tung‐Ping Su
Progress in brain research (2023), pp. 149-168
Closed Access | Times Cited: 1

Mycotherapeutics Affecting Dopaminergic Neurotransmission to Exert Neuroprotection
Shannon Kim, Rishi Nadar, Jack DeRuiter, et al.
(2023), pp. 369-392
Closed Access

Page 1

Scroll to top